ALR Technologies SG (ALRTF) Liabilities and Shareholders Equity (2021 - 2025)
ALR Technologies SG's (ALRTF) quarterly Liabilities and Shareholders Equity came in at $47374.0 in Q4 2025, down 40.39% YoY from $79472.0 in Q4 2024, and up 52.81% on a QoQ basis from $31002.0 in Q2 2025.
ALR Technologies SG (ALRTF) Liabilities and Shareholders Equity (2021 - 2025) Analysis & Trends
ALR Technologies SG (ALRTF) has 5 years of Liabilities and Shareholders Equity data on file, last reported at $47374.0 in Q4 2025.
- Quarterly Liabilities and Shareholders Equity fell 40.39% year-over-year to $47374.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $203688.0 (down 78.81% YoY) and the FY2025 annual result came in at $47374.0, down 40.39% from the prior year.
- Liabilities and Shareholders Equity improved to $47374.0 in Q4 2025, from $31002.0 in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $680562.0 in Q2 2023 to a low of $31002.0 in Q2 2025.
- A 5-year average of $201244.2 and a median of $117335.0 in 2023 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 95.27% — and 2024, when it slumped 93.26%.
- Tracing ALRTF's Liabilities and Shareholders Equity over 5 years: stood at $193217.0 in 2021, then surged by 95.27% to $377289.0 in 2022, then sank by 58.86% to $155198.0 in 2023, then slumped by 48.79% to $79472.0 in 2024, then sank by 40.39% to $47374.0 in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $47374.0 (Q4 2025), $31002.0 (Q2 2025), and $79472.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 10.74 Bn |
| 10 | ALR Technologies SG | 12.91 Mn | 12.89 Mn | - | 47,374.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 47,374.00 |
| Jun 30, 2025 | 31,002.00 |
| Dec 31, 2024 | 79,472.00 |
| Jun 30, 2024 | 45,840.00 |
| Dec 31, 2023 | 155,198.00 |
| Jun 30, 2023 | 680,562.00 |
| Dec 31, 2022 | 377,289.00 |
| Dec 31, 2021 | 193,217.00 |